Testicular cancer occurs most often in men in the middle of the ages of 20 and 39, and is the most tasteless form of solid tumour in men in the middle of the ages of 15 and 34. It may also occur in young boys, but only about 3% of all testicular cancer is found in this group. Tumors regularly occur in one testicle, however, 2-3% of tumors can occur in both testicles, whether simultaneously or at a later date. Tumors can also spread to the lymph nodes, the lungs or other organs. It is more tasteless among Caucasians than among men of African and Asian descent.
Causes
Although the exact cause of testicular carcinoma is unknown, any factors seem to growth risk. These comprise a past medical history of undescended testicle(s), abnormal testicular development, Klinefelter's syndrome (a sex chromosome disorder that may be characterized by low levels of male hormones, sterility, development of breasts, and small testes), men whose mothers used diethylstilbestrol while pregnancy, or men who have had old testicular cancer. There is no link in the middle of vasectomy
and elevated risk of testicular cancer.
Testicular Cancer
Signs and Symptoms
The first sign is regularly a firm, painless, plane testicular mass which is sometimes accompanied by a feeling of heaviness in the testicles. Other symptoms of testicular cancer include: a feeling of swelling in the scrotum, discomfort or pain in the scrotum, ache in the lower back, pelvis or groin area, variety of fluid in the scrotum, gynecomastia and nipple tenderness. In industrialized stages symptoms include: ureteral obstruction, abdominal mass, coughing, shortness of breath, weight loss, fatigue, pallor and lethargy.
Treatment
Testicular carcinoma can be treated with surgery, radiation therapy, chemotherapy, surveillance, or a blend of these treatments. Testicular cancer may be more difficult to treat if it has spread to the liver, bones, or brain, but even in those cases, men can often be cured. If the cancer is a recurrence of a old tumour, the medicine regularly consists of chemotherapy using combinations of dissimilar medications, such as ifosfamide, cisplatin, etoposide, or vinblastine, sometimes followed by an autologous bone marrow or peripheral stem-cell transplant.
While it may be possible, in some cases, to remove testicular cancer tumors from a testis while leaving the testis functional, this is practically never done, as more than 95% of testicular tumors are malignant. regularly the scrotum is not removed so that prosthesis can be put in place. Hormone transfer therapy may be needed after bilateral orchiectomy (removal of both testes). medicine for this condition does not regularly influence sexuality, masculinity or erectile function.
Prognosis
Testicular cancer has one of the highest cure rates of all cancers: in excess of 90%; essentially 100% if it has not metastasized. Less than five percent of those who have testicular cancer will have it again in the remaining testis.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น